Novatek Requalified for Emergent BioSolutions (PaxVax) San Diego, CA Operations
We’re pleased to be a requalified vendor after the recent Emergent BioSolutions acquisition of specialty vaccines company Paxvax. Novatek regulatory compliant quality solutions will continue to be in use at the PaxVax San Diego, CA manufacturing site.
Novatek’s solutions are dedicated to managing multiple critical aspects of a quality-controlled environment. Our software is a business ready, process specific “off the shelf” (OTS) solution that meets 95+ percent of our client user requirements. With a globally proven deployment process, we are confident that we will be able to meet the needs of everchanging environment for Emergent BioSolutions recently acquired PaxVax manufacturing site.
About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.
